SPECIES-DIFFERENCES IN BLOOD PROFILES, METABOLISM AND EXCRETION OF C-14 PROPOFOL AFTER INTRAVENOUS DOSING TO RAT, DOG AND RABBIT

被引:65
作者
SIMONS, PJ
COCKSHOTT, ID
DOUGLAS, EJ
GORDON, EA
KNOTT, S
RUANE, RJ
机构
[1] Safety of Medicines Department, ICI Pharmaceuticals, Alderley Park, Macclesfield, Cheshire
关键词
D O I
10.3109/00498259109043199
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Bolus i.v. doses of C-14-propofol (7-10 mg/kg) to rat, dog and rabbit, or an infusion dose (0.47 mg/kg per min for 6 h) to dog were eliminated primarily in urine (60-95% dose); faecal elimination (13-31%) occurred for rat and dog, but was minimal (< 2%) for rabbit. 2. After bolus administration, blood C-14 concentrations were maximal (8-30-mu-g equiv./ml) at 2-15 min; these declined rapidly during the 0-2 h period and thereafter more slowly. Propofol concentrations were maximal (4-16-mu-g/ml) at 2 min and the profiles were best fitted by a tri-exponential (rat and dog) or bi-exponential (rabbit) equation. Duration of sleep ranged from 5 to 8 min. 3. Infusion of C-14-propofol in dog gave a blood C-14 concentration of 117-mu-g equiv./ml at the end of the 6 h infusion period; this declined at a similar rate to that after the bolus dose. Propofol concentration on termination of infusion was 13-mu-g/ml; thereafter, propofol concentrations declined less rapidly than after the bolus dose. Waking occurred about 44 min post-infusion. 4. Propofol was cleared by conjugation of the parent molecule or its quinol metabolite; hydroxylation of an isopropyl group also occurred in rat and rabbit. Biliary excretion leading to enterohepatic recirculation, and in turn increased sulphate conjugation, occurred in rat and dog, but not rabbit, resulting in a marked interspecies variation in drug clearance and metabolite profiles.
引用
收藏
页码:1243 / 1256
页数:14
相关论文
共 34 条
[1]   ESTIMATION OF ICI 35,868 (DIPRIVANR) IN BLOOD BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, FOLLOWING COUPLING WITH GIBB REAGENT [J].
ADAM, HK ;
DOUGLAS, EJ ;
PLUMMER, GF ;
COSGROVE, MB .
JOURNAL OF CHROMATOGRAPHY, 1981, 223 (01) :232-237
[2]   PHARMACOKINETIC EVALUATION OF ICI-35868 IN MAN - SINGLE INDUCTION DOSES WITH DIFFERENT RATES OF INJECTION [J].
ADAM, HK ;
BRIGGS, LP ;
BAHAR, M ;
DOUGLAS, EJ ;
DUNDEE, JW .
BRITISH JOURNAL OF ANAESTHESIA, 1983, 55 (02) :97-103
[3]  
BILLINGS RE, 1983, J PHARMACOL EXP THER, V225, P630
[4]   THE SYSTEMIC BIOAVAILABILITY OF BUPRENORPHINE BY VARIOUS ROUTES OF ADMINISTRATION [J].
BREWSTER, D ;
HUMPHREY, MJ ;
MCLEAVY, MA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (08) :500-506
[5]  
CASSIDY MK, 1984, DRUG METAB DISPOS, V12, P619
[6]   PHARMACOKINETICS OF PROPOFOL IN FEMALE-PATIENTS - STUDIES USING SINGLE BOLUS INJECTIONS [J].
COCKSHOTT, ID ;
BRIGGS, LP ;
DOUGLAS, EJ ;
WHITE, M .
BRITISH JOURNAL OF ANAESTHESIA, 1987, 59 (09) :1103-1110
[7]  
COCKSHOTT ID, 1990, EUR J ANAESTH, V7, P265
[8]  
COCKSHOTT ID, 1991, UNPUB XENOBIOTICA
[9]  
GEPTS E, 1987, ANESTH ANALG, V66, P1256
[10]   PHARMACOLOGY OF AN EMULSION FORMULATION OF ICI-35868 [J].
GLEN, JB ;
HUNTER, SC .
BRITISH JOURNAL OF ANAESTHESIA, 1984, 56 (06) :617-626